- Home
- CBRL vs NUVB Comparison
CBRL vs NUVB Comparison
Compare CBRL & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRL
- NUVB
- Stock Information
- Founded
- CBRL 1969
- NUVB 2018
- Country
- CBRL United States
- NUVB United States
- Employees
- CBRL N/A
- NUVB N/A
- Industry
- CBRL Restaurants
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- CBRL Consumer Discretionary
- NUVB Health Care
- Exchange
- CBRL Nasdaq
- NUVB Nasdaq
- Market Cap
- CBRL 826.1M
- NUVB 679.9M
- IPO Year
- CBRL N/A
- NUVB N/A
- Fundamental
- Price
- CBRL $57.18
- NUVB $2.26
- Analyst Decision
- CBRL Hold
- NUVB Strong Buy
- Analyst Count
- CBRL 9
- NUVB 5
- Target Price
- CBRL $52.43
- NUVB $8.20
- AVG Volume (30 Days)
- CBRL 807.5K
- NUVB 3.0M
- Earning Date
- CBRL 05-29-2025
- NUVB 05-07-2025
- Dividend Yield
- CBRL 1.76%
- NUVB N/A
- EPS Growth
- CBRL N/A
- NUVB N/A
- EPS
- CBRL 1.60
- NUVB N/A
- Revenue
- CBRL $3,506,050,000.00
- NUVB $10,957,000.00
- Revenue This Year
- CBRL $1.82
- NUVB $95.27
- Revenue Next Year
- CBRL $1.81
- NUVB $345.44
- P/E Ratio
- CBRL $35.71
- NUVB N/A
- Revenue Growth
- CBRL 2.26
- NUVB N/A
- 52 Week Low
- CBRL $33.85
- NUVB $1.54
- 52 Week High
- CBRL $65.43
- NUVB $3.97
- Technical
- Relative Strength Index (RSI)
- CBRL 79.48
- NUVB 58.04
- Support Level
- CBRL $41.73
- NUVB $2.09
- Resistance Level
- CBRL $57.44
- NUVB $2.25
- Average True Range (ATR)
- CBRL 2.16
- NUVB 0.16
- MACD
- CBRL 1.52
- NUVB -0.00
- Stochastic Oscillator
- CBRL 98.51
- NUVB 49.11
About CBRL Cracker Barrel Old Country Store Inc
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. Its restaurants are open for breakfast, lunch, and dinner, with menus that offer home-style country food. Cracker Barrel's biggest input costs are beef, dairy, fruits and vegetables, pork, and poultry. The company purchases its food products from a few different vendors on a cost-plus basis. All restaurants are located in freestanding buildings and include gift shops, which contribute roughly one fourth of total company revenue. Apparel and accessories are the company's biggest revenue generators in the retail segment of the business.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).